Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study

被引:16
|
作者
Malagu, Michele [1 ]
Vitali, Francesco [1 ]
Brieda, Alessandro [1 ]
Cimaglia, Paolo [1 ]
De Raffele, Martina [1 ]
Tazzari, Enea [1 ]
Musolino, Cristina [1 ]
Balla, Cristina [1 ]
Serenelli, Matteo [1 ]
Cultrera, Rosario [2 ]
Rapezzi, Claudio [1 ]
Bertini, Matteo [1 ]
机构
[1] S Anna Univ Hosp, Cardiol Ctr, Via Aldo Moro 8, I-44124 Cona Ferrara, Italy
[2] S Anna Univ Hosp, Infect Dis Unit, Ferrara, Italy
来源
EUROPACE | 2022年 / 24卷 / 03期
关键词
Cardiac implantable electronic device; Infection; Antibiotic prophylaxis; Pacemaker; Implantable cardioverter-defibrillator; Shariff score; PREVENTION; PACEMAKER; BIOFILM; RATES; MICROBIOLOGY; PATHOGENESIS; MORTALITY;
D O I
10.1093/europace/euab222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims In patients undergoing cardiac implantable electronic device (CIED) intervention, routine pre-procedure antibiotic prophylaxis is recommended. A more powerful antibiotic protocol has been suggested in patients at high risk of infection. Stratification of individual infective risk could guide the prophylaxis before CIED procedure. Methods and results Patients undergoing CIED surgery were stratified according to the Shariff score in low and high infective risk. Patients in the 'low-risk' group were treated with only two antibiotic administrations while patients in the 'high-risk' group were treated with a prolonged 9-day protocol, according to renal function and allergies. We followed-up patients for 250 days with clinical outpatient visit and electronic control of the CIED. As primary endpoint, we evaluated CIED-related infections. A total of 937 consecutive patients were enrolled, of whom 735 were stratified in the 'low-risk' group and 202 in the 'high-risk' group. Despite different risk profiles, CIED-related infection rate at 250 days was similar in the two groups (8/735 in 'low risk' vs. 4/202 in 'high risk', P = 0.32). At multivariate analysis, active neoplasia, haematoma, and reintervention were independently associated with CIED-related infection (HR 5.54, 10.77, and 12.15, respectively). Conclusion In a large cohort of patients undergoing CIED procedure, an antibiotic prophylaxis based on individual stratification of infective risk resulted in similar rate of infection between groups at high and low risk of CIED-related infection.
引用
收藏
页码:413 / 420
页数:8
相关论文
共 50 条
  • [21] Infectious consequences of hematoma from cardiac implantable electronic device procedures and the role of the antibiotic envelope: A WRAP-IT trial analysis
    Tarakji, Khaldoun G.
    Korantzopoulos, Panagiotis
    Philippon, Francois
    Biffi, Mauro
    Mittal, Suneet
    Poole, Jeanne E.
    Kennergren, Charles
    Lexcen, Daniel R.
    Lande, Jeff D.
    Seshadri, Swathi
    Wilkoff, Bruce L.
    HEART RHYTHM, 2021, 18 (12) : 2080 - 2086
  • [22] Cardiac Implantable Electronic Device Infection in Patients at Risk
    Tarakji, Khaldoun G.
    Ellis, Christopher R.
    Defaye, Pascal
    Kennergren, Charles
    ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2016, 5 (01) : 65 - 71
  • [23] Forty-Year Trends in Cardiac Implantable Electronic Device Infective Endocarditis
    Hernandez-Meneses, Marta
    Llopis, Jaume
    Sandoval, Elena
    Ninot, Salvador
    Almela, Manel
    Falces, Carlos
    Pericas, Juan M.
    Vidal, Barbara
    Perissinotti, Andres
    Marco, Francesc
    Mestres, Carlos A.
    Pare, Carlos
    Garcia de la Maria, Cristina
    Cuervo, Guillermo
    Quintana, Eduard
    Tolosana, Jose M.
    Moreno, Asuncion
    Miro, Jose M.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):
  • [24] The Burden and Risk Factors for Infection of Transvenous Cardiovascular Implantable Electronic Device: a Nationwide Cohort Study
    Yang, Pil-Sung
    Jeong, Jaehan
    You, So-Jeong
    Yu, Hee Tae
    Kim, Tae-Hoon
    Sung, Jung-Hoon
    Lee, Sang-Soo
    Park, Hyung-Deuk
    Joung, Boyoung
    KOREAN CIRCULATION JOURNAL, 2019, 49 (08) : 742 - 752
  • [25] Cardiac Implantable Electronic Device Infections: Facts, Current Practice, and the Unanswered Questions
    Khaldoun G. Tarakji
    Bruce L. Wilkoff
    Current Infectious Disease Reports, 2014, 16
  • [26] Risk of Cardiac Implantable Electronic Device Infection after Early versus Delayed Lead Repositioning
    Schvartz, Noemi
    Haidary, Arian
    Wakili, Reza
    Hecker, Florian
    Kupusovic, Jana
    Zsigmond, Elod-Janos
    Miklos, Marton
    Saghy, Laszlo
    Szili-Torok, Tamas
    Erath, Julia W.
    Vamos, Mate
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (04)
  • [27] Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis
    Polyzos, Konstantinos A.
    Konstantelias, Athanasios A.
    Falagas, Matthew E.
    EUROPACE, 2015, 17 (05): : 767 - 777
  • [28] Complex cardiac implantable electronic device infections in Alberta, Canada: An epidemiologic cohort study of validated administrative data
    King, Teagan L.
    Chew, Derek S.
    Leal, Jenine
    Cannon, Kristine
    Exner, Derek V.
    Smith, Stephanie
    Larios, Oscar
    Bush, Kathryn
    Yuen, Brian
    Zhang, Zuying
    Rennert-May, Elissa
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2023, 44 (10) : 1607 - 1613
  • [29] Risk Factors of Haematoma Formation Following Cardiac Implantable Electronic Device Procedures
    Wang, Benjamen
    Yao, Jessica
    Sethwala, Anver
    Hawson, Joshua
    Stevenson, Irene
    HEART LUNG AND CIRCULATION, 2022, 31 (11) : 1539 - 1546
  • [30] Cardiac implantable electronic device infection: prevalence and risk factors
    Ghazaryan, N. L.
    Khachatryan, A. H.
    Adamyan, M. Yu
    Hovakimyan, T. B.
    NEW ARMENIAN MEDICAL JOURNAL, 2022, 16 (04): : 96 - 101